OR WAIT null SECS
August 02, 2022
Pharmaceutical Technology spoke with Ed Gump, VP Small Molecules at the US Pharmacopeia (USP) about API quality from the standards perspective.
July 08, 2022
VeriSIM Life and Mayo Clinic are collaborating to develop new promising drug candidates.
NRG Therapeutics and Domainex aim to develop novel small-molecule drugs to treat neurodegenerative disorders, such as Parkinson’s disease.
LG Chem has decided to proceed with IND-enabling studies and has renewed a license with Avacta.
July 03, 2022
Lack of toxicity data and poor physicochemical properties must be overcome.
June 27, 2022
ImmunoGen has formed a research collaboration with Oxford BioTherapeutics to develop novel antibody-drug conjugates for cancers with high unmet needs.
June 03, 2022
The right processes used with the right excipient combinations address evolving formulation needs.
May 26, 2022
Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.
Lubrizol has launched Apisolex technology to improve solubility and simplify the manufacturing of parenteral drug products.
May 03, 2022
Resolving operational bottlenecks makes mAb manufacturing more efficient.
